CSPC Pharmaceutical Group Limited reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 23,495.52 million compared to CNY 20,641.75 million a year ago. Net income was CNY 4,467.84 million compared to CNY 4,335.3 million a year ago.

Basic earnings per share from continuing operations was CNY 0.3749 compared to CNY 0.3626 a year ago. Diluted earnings per share from continuing operations was CNY 0.3749 compared to CNY 0.3626 a year ago.